top of page

Biotech General Discussion

Public·93 members

More Biopharma Stock Ideas from Q3 Hedge Fund Activity

You can find updated Q3 bioHF holdings data at app.bpiq.com/hedgefunds

  • Check out the ticker screener

  • If you are an Elite or Amp subscriber ...

  • Check out the tables at the links on the left menu under "Hedge Funds"

  • If not, sign up today HERE 


Our goal is to help you make $$ investing in biopharma

That's why we follow top biopharma hedge funds (bioHFs) ^1


Here are some tickers to check out based on Q3 hedge fund activity

  • Tickers most initiated or closed by bioHF in Q3 '23

  • Most initiated

  • $RYZB $APGE $TSHE $SGMT $IMVT $SLNO $CMPS $GOSS

  • Most closed

  • $BDTX $VIR $THRX $MRSN


More details ...

👇 Initiated by the most bioHFs in Q3 '23

• Based on 9/30/23 13F filings


⇨ 2 newly IPOed

  • RYZB (10 vs. 0)  (# bioHFs that held ticker on 9/30/23 vs. 6/30/23)

  • 9/19/23 IPO

  • Ph1 SCLC & endocrine tumors

  • RYZB pipeline


  • APGE (9 vs. 0)

  • 7/13/23 IPO

  • Ph1 Atopic derm

  • APGE pipeline


⇨ 1 more with very early stage assets

  • TSHA (8 vs. 0)  (^2)

  • Ph1/2 Rett Syndrome

  • TSHA pipeline


⇨ 1 whose stock took a big plunge since end of Q3

  • SGMT (5 vs. 0)

  • Stock heading down since end Q2 (~12.50 to ~$3.63) but no readouts?

  • Upcoming Ph2b catalyst (Q1 2024) in  NASH

  • SGMT 1 yr stock chart



⇨ 2 that had big mover positive readouts near end of last quarter

  • IMVT (14 vs. 6)

  • 9/26/23

  • Ph1 auto-immune disease

  • IMVT-14-2 anti-FcRn Ab for various auto-immune diseases

  • pipeline in asset-type asset

  • IMVT 1 yr stock chart


  • SLNO (7 vs. 1)

  • 9/26/23

  • Ph3 in PWS (rare disease - hyperphagia - eating disorder)

  • SLNO 1 yr stock chart


⇨ 1 with an important upcoming readout

  • CMPS (7 vs. 1)

  • Ph3 depression - Summer 2024

  • Only Deep Track had it previously

  • CMPS pipeline


⇨ 1 whose stock was crushed at end of 2022

  • GOSS (10 vs 5)

  • Lots of bioHFs for a micro-cap

  • EV <$200M

  • 4 top 20s is high too

  • Ph2 update 12/18/23 for only clinical asset

  • GOSS stock chart



--------

👇 As far as bioHF positions closed,

  • Not as many closed as initiated


⇨ Most bioHF closed in Q3 '23

  • Positions closed by 3 HFs

  • BDTX (5 vs. 8)

  • VIR (2 vs. 5)

  • THRX (3 vs. 6)

  • MRSN (8 vs. 11)


------

SUMMARY

  • These tickers are good ones to dig deeper into

  • Or if you already hold these tickers

  • take the info above as reinforcing, or a caution


------

^1 We identified & follow moves of 36 top BioHFs

⇨ That focus on biopharma stocks & have over $250M in AUM

^2 Confirm with your Hedge Fund data provider that there were no holdings for this ticker in Q2 to assure our provider's data is accurate, since the move from 0 to 8 is quite unusual for a company that went public before Q2


------

This article is not investment, tax, or legal advice. Please do your own diligence and seek advice from professional advisors representing your interests.  


Article history:

Posted 12/20/23 (EJV)


#RYZB #APGE #TSHE #SGMT #IMVT #SLNO #CMPS #GOSS #BDTX #VIR #THRX #MRSN

17 Views
bottom of page